Wednesday, 29 October 2014

Time: 17:30-19:00  Room: Auditorium

Sir John Crofton Memorial Lecture: "The role of legislative advocacy for TB and other lung health conditions"

Speaker: Rt Hon. Nick Herbert, MP and co-chair of the All Party Parliamentary Group on Global TB (UK)

"Old disease, new ambitions: Zero TB deaths in our lifetime"

Speaker: Dr Aaron Motsoaledi, Minister of Health for South Africa & Chair of the Stop TB Partnership Board

"The role of communities in the management and care of persons living with tuberculosis, HIV and other lung health issues"

Speaker: Ria Grant

Chairs: E Jane Carter (USA), Rajita Bhavaraju (USA)


Nick Herbert (UK)

Nick Herbert is the UK Member of Parliament for Arundel and South Downs. He was first elected in 1997 as the Conservative Parliamentary member from Berwick Upon Tweed, one of the most rural seats in England.  Herbert is passionate about defending rural communities and played a leading role in what is now the Countryside Alliance. He also directed the highly regarded independent think tank, Reform.

In Parliament, he has held the positions of Shadow Minister for Police Reform, Shadow Secretary of State for Justice and Shadow Secretary of State for Environment, Food and Rural Affairs.  Herbert also served as Minister of State for Policing and Criminal Justice from 2010 to 2012.

Since becoming an MP, Herbert has worked closely with the development charity Results on the global problem of tuberculosis.  In 2006 he helped to form, and was elected co-chairman of, the All Party Parliamentary Group on Global TB.  He returned as co-chairman in 2013. 

Aaron Motsoaledi (South Africa)

Dr Aaron Motsoaledi, Minister of Health for South Africa & Chair of the Stop TB Partnership Board

Aaron Motsoaledi has been South Africa's Minister of Health since 2009. Dr Motsoaledi became politically aware at a young age. He was in high school at the time of the Soweto uprisings of 1976, and he was active in the liberation struggle as a college and medical student. In 1983 he was instrumental in mobilising students at the University of Natal to form the United Democratic Front.  As a medical intern, he was involved in the African National Congress’s armed wing, and in 1980 he was elected chair of the Northern Transvaal Reception Committee. He became deputy chair of the ANC Northern Transvaal (now Limpopo) region when it was launched in 1990 and served on the Limpopo Provincial Executive Committee of the ANC for 19 years.  He was then elected to the ANC National Executive Committee, where he serves today.

Dr Motsoaledi holds bachelors’ degrees in medicine and surgery from the University of KwaZulu-Natal and is a member of the Ministerial Advisory Committee for the NHI and South African National AIDS Council.

Ria Grant (South Africa)

Ria Grant is both Senior Advisor for South Africa’s TB/HIV Care Association and a member of the Developing Country NGO Delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund).

As a long-time TB nurse in the Cape Town area, Mrs Grant became aware of how crucial a TB patient’s social environment is to both causing and curing the disease. She then became a caseworker for TB Care – now the TB/HIV Care Association – working closely with patients to address their clinical, material and psychosocial needs. She was appointed Director of TB/HIV Care Association, and since her retirement in 2009, continues as Senior Advisor.

Mrs Grant has also served as African Regional Communications Focal Point and Lead Communications Focal Point for the Developing Country NGO Delegation to The Global Fund, among other commitments.  She has presented papers on TB/HIV Care's work internationally to communicate the importance of its mission.

Thursday, 30 October 2014

Richard Riley Plenary Session

Time: 11:30 - 12:30  Room: Auditorium

"WHO’s new End TB Strategy 2016-2035"

Chair: Edward Nardell (USA)

Speaker: Mukund Uplekar, Senior Offier, Policy, Strategy and Innovations Unit, The Global TB Programme, World Health Organization (WHO), Switzerland

"New models of lung health and diabetes care for the poor accessing private providers in Asia"

Chair: Laia Ruiz Mingote (Spain)

Speaker: Aamir Khan


Mukund Uplekar (Switzerland)

Dr Mukund Uplekar is a senior medical officer in the Policy, Strategy and Innovations unit of the Global TB Programme at the World Health Organization in Geneva. He began his career in private medical practice in Mumbai, India, but, after a year at the Harvard School of Public Health, he switched to international public health. His exposure to both the private sector and public health research in India attracted him to WHO, which he joined in 1999 to help develop and expand work in the area now recognised as public-private mix (PPM). Since its inception, he has led the WHO-based secretariat of the global Subgroup on PPM for TB care and control.

Dr Uplekar also coordinated the development and drafting of WHO’s Expanded DOTS Strategy in 2002 and the Stop TB Strategy in 2006. He also led the team that put together over a period of two years, WHO’s new post-2015 “End TB Strategy” endorsed by the World Health Assembly in May 2014.

Aamir Khan (Pakistan)

Dr Aamir Khan is the Founder of Interactive Research and Development (IRD) and has served as Executive Director since 2004. IRD is a social enterprise incubator committed to improving global health and development through the use of information technologies and market innovations. Current projects focus on MDR-TB treatment and lung health and diabetes care for the poor in Asia and TB-HIV screening and treatment in Africa. Supported by its operational hub in Dubai, IRD implementation teams work in over 15 countries.

Dr Khan trained in medicine and public health at the Aga Khan University and completed his PhD in international health at Johns Hopkins University (JHU). As an Associate of JHU’s Bloomberg School of Public Health, he has worked on infectious disease research for the past 18 years. He is also an inaugural Board Member of OpenMRS and a founding member of openSRP, open source software for medical records and frontline public health workers.

Friday, 31 October 2014

Time: 11:30 - 12:30 Room: Auditorium

"Past and future examples of community engagement"

Speaker: Mark Dybul, Executive Director of The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland

"Robert Koch Lecture on TB vaccines development"

Chair: Pere-Joan Cardona (Spain)

Speaker: Stefan H E Kaufmann, Founding Director and Managing Director of the Max Planck Institute for Infection Biology in Berlin, Germany


Mark Dybul (Switzerland)

Dr Mark Dybul is the Executive Director of The Global Fund to Fight AIDS, Tuberculosis and Malaria. Dybul has worked on HIV and public health for more than 25 years as a clinician, scientist, teacher and administrator.

A graduate of Georgetown Medical School, he joined the National Institute of Allergy and Infectious Diseases, where he conducted HIV research, including the first randomised, controlled clinical trial with combination antiretroviral therapy in Africa. He was a driving force behind the creation of the President’s Emergency Plan for AIDS Relief (PEPFAR) and became its leader as US Global AIDS Coordinator from 2006 to 2009. He went on to serve as co-director of the Global Health Law Program at Georgetown, where he was also a Distinguished Scholar. In 2012 he was appointed to his current position as Executive Director of The Global Fund.

Stefan H E Kaufmann (Germany)

Prof Stefan H E Kaufmann is the Founding Director and Managing Director of the Max Planck Institute for Infection Biology in Berlin, where he heads the Department of Immunology. He is also Professor for Microbiology and Immunology at Charité University Clinics Berlin.

Author of more than 700 papers, Prof Kaufmann’s current scientific interests focus on immunity to bacterial pathogens with emphasis on tuberculosis and rational vaccine and biomarker design. He is the co-developer of a recombinant BCG vaccine candidate, which is in a phase II clinical trial, and the coordinator of several other international and interdisciplinary projects. His professional activities have ranged from serving as an Alternate Board Member for the GAVI Alliance and editorship more than 20 scientific journals to participation in numerous professional societies and initiation of the Day of Immunology, which raises awareness of the importance of immunology to health and well-being.

Saturday, 1 November 2014

Time: 11:30 - 12:30  Room: Auditoium

"Panel discussion: Community driven solutions: present perspectives and future vision"

Speakers: Patrick Nsimba Mata, TB advocate, Deputy National Secretary and Project Coordinator for Club des Amis Damien, Democratic Republic of Congo; Edith Garba, lawyer and MDR-TB survivor, Nigeria; Mesake Navugona, rugby league player at 2000 World Cup and former TB patient, Fiji; Oleksandr Kulchenko, Treatment Programmes Support Unit, All-Ukrainian Network of People Living with HIV, Ukraine

Moderators: Oxana Rucsineanu (Moldova), D’Arcy Richardson (USA)


Patrick Nsimba Mata, TB advocate; Deputy National Secretary and Project Coordinator for Club des Amis Damien (Democratic Republic of Congo)

Patrick Nsimba Mata is a former TB patient from the DR Congo, who has been an activist in the fight against TB since 2001. He joined the Club des Amis Damien (CAD) where he took on the role of referring possible TB patients, offering psychosocial support to critically ill patients and providing information to communities. Formerly trained as a mathematician and physicist, he has since completed undergraduate and graduate degrees in international relations. Through this advocacy work, he has also received extensive training in skills from HIV testing and counselling to computer skills.  In 2013, he participated in the external review of the National TB Control Programme. He is the Deputy National Secretary and Project Coordinator for CAD and an Alternate Member of the Global Fund/DRC CCM representing TB patients.

Edith Garba, lawyer and MDR-TB survivor (Nigeria)

Edith Garba was raised in Kaduna state in northern Nigeria. She attended the Ahmadu Bello University Zaria Nigeria and Nigerian Law School and is a lawyer by profession. She successfully completed her 20-month multi-drug resistant tuberculosis (MDR-TB) treatment without any adverse effects. The testimony of her treatment success is summarised in the poem "MDR-TB Leap". She was an active participant in the National Strategic Plan (NSP) workshop held in Nigeria in November 2013 and is currently a member of the Global Drug-Resistant Initiative (GDI).

Mesake Navugona, rugby league player at 2000 World Cup and former TB patient (Fiji)

Mesake Navugona comes from Fiji, where he is a plumber by trade and works as a Technical Officer for Fiji’s Water Authority. He has been involved with sports since he was 10 years old and has represented Fiji in soccer, rugby and rugby league. He does a great deal of voluntary work helping the young people with sports and managing the National Rugby League teams at various overseas tournaments. He is a TB survivor and advocate who helps Fiji’s young people through awareness programmes.

Oleksandr Kulchenko, Treatment Programmes Support Unit, All-Ukrainian Network of People Living with HIV (Ukraine)